Ganoderma Lucidum (Reishi mushroom) for cancer treatment

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Jin, Xingzhong ^a   Ruiz Beguerie, Julieta ^a   Sze, Daniel Man Yeun ^b   Chan, Godfrey C F ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; COMPLEMENT COMPONENT C3; DECTIN 1; GANODERMA LUCIDUM EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PLACEBO; POLYSACCHARIDE; PROTEIN KINASE C; TOLL LIKE RECEPTOR 2; TRITERPENE;

ADAPTIVE IMMUNITY; ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; ARTERIOSCLEROSIS; ARTHRITIS; BRONCHITIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CELL PROLIFERATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; GANODERMA LUCIDUM; HEPATITIS; HUMAN; HYPERTENSION; IMMUNOMODULATION; INFORMATION RETRIEVAL; INNATE IMMUNITY; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LIVER TOXICITY; MACROPHAGE; MEDICAL LITERATURE; MONOCYTE; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; NEOPLASM; NEPHRITIS; NEUTROPHIL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHAGOCYTOSIS; QUALITY OF LIFE; RASH; REVIEW; SENSITIVITY ANALYSIS; SOLID TUMOR; STOMACH ULCER; SYSTEMATIC REVIEW; TARGET CELL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 70349114319     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007731     Document Type: Review

References (20)

1. Boh B, Berovic M, Zhang J, Zhi-Bin L. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnology Annual Review 2007;13:265-301. (Pubitemid 47387127)
2. Brown GD. Dectin-1: a signalling non-TLR pattern recognition receptor. Nature Reviews Immunology 2006;6(1):33-43. (Pubitemid 43279751)
3. Chan WK, Lam DT, Law HK, Wong WT, Koo MV, Lau AS, et al. Ganoderma Lucidummycelium and spore extracts as natural adjuvants for immunotherapy. Journal of Alternative and Complementary Medicine 2005;11(6):1047-1057
4. Chan WK, Law HK, Lin ZB, Lau YL, Chan GC. Response of human dendritic cells to different immunomodulatory polysaccharides derived frommushroom and barley. International Immunology 2007; 19(7):891-899
5. Chang ST, Buswell JA. Ganoderma Lucidum - A mushrooming medicinal Mushroom. International Journal of Medicinal Mushroom 1999;1:139-146
6. Chinn S. A Simple Method for Converting An Odds Ratio to Effect Size for use in Meta-analysis. Statistics in Medicine 2000;19(22): 3127-3131 (Pubitemid 30834857)
7. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
8. Flanagan JC. Measurement of quality of life: current state of the art. Archives of Physical Medicine and Rehabilitation 1982;63:56-59 (Pubitemid 12184693)
9. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. The Journal of Experimental Medicine 2003;197 (9):1107-1117 (Pubitemid 36570066)
10. Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine 2005;25:3443-3457 (Pubitemid 44575162)
11. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring Inconsistency in Meta-analyses. BMJ 2003;327:557-560
12. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, et al. Mechanism by which orally administered beta-1-3-glucans enhance the tumoricidal activity of antitumour monoclonal antibodies in murine tumour models. The Journal of Immunology 2004;173(2):797-806. (Pubitemid 38924254)
13. Jong SC, Birmingham JM. Medicinal benefits of the mushroom Ganoderma. Advances in Applied Microbiology 1992;37:101-134
14. Lee S, Park S, Oh JW, Yang C. Natural inhibitors for protein prenyl transferase. Planta Medica 1998;64:303-308 (Pubitemid 28234264)
15. Min BS, Gao JJ, Nakamura N, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against Meth-A and LLC tumor cells. Chemical and Pharmaceutical Bulletin 2000; 48:1026-1033 (Pubitemid 30485402)
16. Oncology Nursing Society (ONS). Chemotherapy and biotherapy guidelines and recommendations for practice. Oncology Nursing Society, 2005.
17. Patrick T, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New Guidelines to Evaluate the Response to Treatment in Solid Tumors. Journal of the National Cancer Institute 2000;92: 205-216 (Pubitemid 30099779)
18. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. Integrative Cancer Therapies 2003;2:358-364 (Pubitemid 37444432)
19. Steward BW, Kleihues P, World Health Organization. World Cancer Report 2003. IARC Press, 2003.
20. Upton R. American Herbal Pharmacopoeia: Reishi Mushroom. American Herbal Pharmacopoeia, Sep 2000.